MicroRNA-143 Regulates Adipocyte Differentiation

Christine Esau(Ionis Pharmaceuticals (United States)), Xiaolin Kang(Ionis Pharmaceuticals (United States)), Eigen Peralta(Ionis Pharmaceuticals (United States)), Elaine Hanson(Ionis Pharmaceuticals (United States)), Eric G. Marcusson(Ionis Pharmaceuticals (United States)), Lingamanaidu V. Ravichandran(Ionis Pharmaceuticals (United States)), Yingqing Sun(Ionis Pharmaceuticals (United States)), Seongjoon Koo(Ionis Pharmaceuticals (United States)), Ranjan J. Perera(Ionis Pharmaceuticals (United States)), Ravi Jain(Ionis Pharmaceuticals (United States)), Nicholas M. Dean(Ionis Pharmaceuticals (United States)), Susan M. Freier(Ionis Pharmaceuticals (United States)), C. Frank Bennett(Ionis Pharmaceuticals (United States)), Bridget Lollo(Ionis Pharmaceuticals (United States)), Richard H. Griffey(Ionis Pharmaceuticals (United States))
Journal of Biological Chemistry
October 26, 2004
Cited by 1,019Open Access
Full Text

Abstract

MicroRNAs (miRNAs) are endogenously expressed 20-24 nucleotide RNAs thought to repress protein translation through binding to a target mRNA (1-3). Only a few of the more than 250 predicted human miRNAs have been assigned any biological function. In an effort to uncover miRNAs important during adipocyte differentiation, antisense oligonucleotides (ASOs) targeting 86 human miRNAs were transfected into cultured human pre-adipocytes, and their ability to modulate adipocyte differentiation was evaluated. Expression of 254 miRNAs in differentiating adipocytes was also examined on a miRNA microarray. Here we report that the combination of expression data and functional assay results identified a role for miR-143 in adipocyte differentiation. miR-143 levels increased in differentiating adipocytes, and inhibition of miR-143 effectively inhibited adipocyte differentiation. In addition, protein levels of the proposed miR-143 target ERK5 (4) were higher in ASO-treated adipocytes. These results demonstrate that miR-143 is involved in adipocyte differentiation and may act through target gene ERK5.


Related Papers